Hepatitis B vaccine immunoresponsiveness in adolescents: A revaccination proposal after primary vaccination

Vaccine

Volumn 14, Issue 2, 1996, Pages 103-106

  Miñana, Juan Simó ^a   Ganuza, Marisol Gaztambide ^b   Millán, Pilar Fernández ^b   Fernández, Marina Peña ^b  

^a Centro de Salud Altabix   (Spain)

^b Ctro de Salud Pub de Elche   (Spain)

Author keywords

Adolescents; Hepatitis B vaccine; Immunoresponsiveness

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEX; VACCINATION;

EID: 0343832252     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00176-2     Document Type: Article

References (20)

1. Hall, A.J. Hepatitis B vaccination: protection for how long and against what? Br. Med. J. 1993, 307, 276-277
2. Guardia, J. Hepatitis por virus B. Gastrum 1989, 42, 24-32
3. Weber, D.J., Rutala, W.A., Samsa, J.P. et al. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. J. Am. Med. Assoc. 1985, 254, 3187-3189
4. CDC. Suboptimal response to hepatitis B vaccine given by injection in the buttock. Morbid. Mortal. Wkly Rep. 1985, 34, 105-108
5. Weber, D.J., Rutala, W.A., Samsa, J.P. et al. Impaired immunogenicity of hepatitis B vaccine in obese persons (letter). N. Engl. J. Med. 1986, 314, 1393
6. Ramón Torrell, J.M., Micheo Salas, C., Cerdó Goicouria, C., Casas Garcia, I. and Escribá Jordana, J.M. Respuesta inmunitaria a la vacuna contra la hepatitis B obtenida por ingeniena genética. Rev. Clin. Esp. 1991, 188, 68-71
7. Ambrosch, F., Frisch-Niggemeyer, W. and Kremsner, P. Persistence of vaccine induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects. Postgrad. Med. J. 1987, 63 (Suppl. 2), 129-135
8. Vandervelde, E.M. and Mortimer, P.P. New hepatitis vaccines. Br. Med. J. 1985, 290, 787
9. Pead, P.J., Saeed, A.A., Hewitt, W.G. et al. Low immune responses to hepatitis B vaccination among healthy subjects. Lancet 1985, 1, 1152
10. André, F.E. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am. J. Med. 1989, 87, 14-20
11. Sheirman, N., Geseman, M., Maurer, C., Just, M. and Berger, R. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules. Vaccine 1990, 8 (Suppl.), 44-45
12. Jilg, W., Schmidt, M. and Deinhardt, F. Decline of antiHBs after hepatitis B vaccination and timing of revaccination. Lancet 1990, 335, 173-174
13. Laplanche, A., Courouce, A.M., Benhamou, E. and Jungers, P. Timming of hepatitis B revaccination in healthy adults. Lancet 1987, 1, 1206-1207
14. Chan, C.-Y, Lee, S.-D., Tsai, Y-T. and Lo, K.-J. Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs responses were initially elicited by a plasma-derived vaccine. Vaccine 1991, 9, 765-767
15. Prince, A.M. Revaccination against hepatitis B. Lancet 1991, 338, 61
16. Coursaget, P., Yvonnet, B., Chotard, J. et al. Seven years study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986, ii, 1143-1145
17. Fortuin, M., Chotard, J., Jack, A.D. et al. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunization. Lancet 1993, 341, 1129-1131
18. Wainwright, R.B., McMahon, B.J., Bulkow, L.R., Parkinson, A.J. and Harpster, A.P. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven years results. Arch. Intern. Med. 1991, 151, 1634-1636
19. Hadler, S.C., Francis, D.P., Maynard, J.E. et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N. Engl. J. Med. 1986, 315, 209-214
20. Stevens, C.E., Toy, P.T., Taylor, P.E., Lee, T. and Hoo-Yi, Yip. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 1992, 90, 170-173